(Q42283686)

19 October 2017

Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia (English)

1 reference

19 October 2017

B Föger

1

1 reference

19 October 2017

H Drexel

2

1 reference

19 October 2017

T Hopferwieser

3

1 reference

19 October 2017

G Miesenböck

4

1 reference

19 October 2017

A Ritsch

5

1 reference

19 October 2017

M Lechleitner

6

1 reference

19 October 2017

G Tröbinger

7

1 reference

19 October 2017

J R Patsch

8

1 reference

19 October 2017

1 March 1994

1 reference

Journal of Molecular Medicine

19 October 2017

1 reference

19 October 2017

72

1 reference

19 October 2017

4

1 reference

19 October 2017

294-301

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00180044

19 October 2017

0 references

cites work

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

12 December 2020

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia

1 reference

12 December 2020

Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.

1 reference

12 December 2020

Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil

1 reference

12 December 2020

Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment

1 reference

12 December 2020

Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia

1 reference

12 December 2020

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study

1 reference

12 December 2020

Structure and biochemical effects of fenofibrate

1 reference

12 December 2020

Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia

1 reference

12 December 2020

Fenofibrate, a third-generation fibric acid derivative

1 reference

12 December 2020

A dual-precipitation method evaluated for measurement of cholesterol in high-density lipoprotein subfractions HDL2 and HDL3 in human plasma

1 reference

12 December 2020

Distribution of lipoprotein lipase and hepatic lipase between plasma and tissues: effect of hypertriglyceridemia

1 reference

12 December 2020

Plasma lipid transfer proteins

1 reference

12 December 2020

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

1 reference

12 December 2020

Polyclonal antibody-based immunoradiometric assay for quantification of cholesteryl ester transfer protein

1 reference

12 December 2020

Effects of fenofibrate on angiographically examined coronary atherosclerosis and left ventricular function in hypercholesterolemic patients

1 reference

12 December 2020

Postprandial lipemia, fenofibrate and coronary artery disease

1 reference

12 December 2020

Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma.

1 reference

12 December 2020

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

1 reference

12 December 2020

Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase

1 reference

12 December 2020

Stimulation of cholesterol ester exchange by lipo-protein-free rabbit plasma

1 reference

12 December 2020

Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects

1 reference

12 December 2020

Plasma triglyceride and coronary heart disease

1 reference

12 December 2020

High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase

1 reference

12 December 2020

Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia

1 reference

12 December 2020

Effect of fibric acid derivatives on blood lipid and lipoprotein levels

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins

1 reference

12 December 2020

A plasma inhibitor of triglyceride and cholesteryl ester transfer activities

1 reference

12 December 2020

Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition

1 reference

12 December 2020

The effect of serum lipid regulation on the development of femoral atherosclerosis in hyperlipidaemia: a non-randomized controlled study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00180044

1 reference

19 October 2017

1 reference